Anti-CD20 (Research Grade Obinutuzumab Biosimilar) sinobiological 68055-H001
| Catalog No. | Size | Price (USD) |
| 68055-H001-5 | 5 mg | $740.55 |
| 68055-H001-25 | 25 mg | $2,221.66 |
| 68055-H001-500 | 500 µg | $222.17 |
| Catalog No. | Size | Price (USD) |
| 68055-H001-5 | 5 mg | $740.55 |
| 68055-H001-25 | 25 mg | $2,221.66 |
| 68055-H001-500 | 500 µg | $222.17 |
General Information
| Product name | Anti-CD20 (Research Grade Obinutuzumab Biosimilar) |
| Species reactivity | Reacts with: Human |
| Specificity | CD20 |
| Preparation | This product is a recombinant monoclonal antibody expressed from HEK293 cells. |
| Source | IgG1, Kappa |
| Purification | Protein A |
| Formulation | Histidine and Arginine buffer containing 120mM NaCl, 0.02% Tween 80, pH6.0 |
| Conjugate | Unconjugated |
| Endotoxin | ≦ 1 EU/mg |
| Form | Liquid |
| Shipping | This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Storage | Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles. |
Image / Experimental Information
| Image 1 Description | ≥95 % as determined by SDS-PAGE. |
| Image 1 Alt Text | Human CD20-Obinutuzumab Enzyme linked immunosorbent assay (ELISA) 45953 |
| Image 1 URL | Source image |
| Image 2 Description | ≥95 % as determined by SDS-PAGE. |
| Image 2 Alt Text | Human CD20-Obinutuzumab Enzyme linked immunosorbent assay (ELISA) 45954 |
| Image 2 URL | Source image |
title: A Pathologically Friendly Strategy for Determining the Organ-specific Spatial Tumor Microenvironment Topology in Lung Adenocarcinoma Through the Integration of snRandom-seq and Imaging Mass Cytometry.
authors: Xuqi Sun; Xiao Teng; ...; Xuanwen Bao
journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
date: 2024-04-29
pmid: 38682485
doi: 10.1002/advs.202308892
cited_by_count: 5
techniques: Amplification; Formalin-fixed Paraffin-Embedded; Imaging; Incubation; Staining
bioz_score: 92
title: Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells.
authors: Sara Cherradi; Véronique Garambois; ...; Maguy Del Rio
journal: Cell & bioscience
date: 2023-04-11
pmid: 37041570
doi: 10.1186/s13578-023-01015-5
cited_by_count: 13
techniques: Control; Cytometry; Cytotoxicity Assay; Fluorescence; Imaging; In Vitro; In Vivo; Incubation; Viability Assay
bioz_score: 92
title: Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient
authors: Xiao-Hong Yao; Zhi-Cheng He; ...; Xiu-Wu Bian
journal: Cell Research
date: 2020-04-28
pmid: 32346074
doi: 10.1038/s41422-020-0318-5
pmcid: 7186763
cited_by_count: 128
bioz_score: 92
title: Moving Forward: Recent Developments for the Ferret Biomedical Research Model
authors: Randy A. Albrecht; Wen-Chun Liu; ...; Thomas E. Morrison
journal: mBio
date: 2018-07-17
pmid: 30018107
doi: 10.1128/mBio.01113-18
pmcid: 6050969
cited_by_count: 48
techniques: Enzyme-linked Immunospot; Immunohistochemistry; Staining
bioz_score: 92
title: Influenza Virus
journal: Methods in Molecular Biology
date: 2018-01-01
doi: 10.1007/978-1-4939-8678-1
cited_by_count: 0
techniques: Cytometry; Diagnostic Assay; Enzyme-linked Immunosorbent Assay; Enzyme-linked Immunospot
bioz_score: 92